Back to Directory

CJC-1295

Growth Hormone Secretagogues

A long-acting growth hormone releasing hormone analog that extends growth hormone pulses.

Key Benefits

  • ✓Increased growth hormone levels
  • ✓Enhanced muscle growth
  • ✓Improved fat metabolism
  • ✓Better recovery and repair
  • ✓Increased bone density
  • ✓Improved cognitive function
  • ✓Enhanced immune system

Dosing Information

Dosage Range
1-2 mg
Frequency
Once or twice per week (with DAC)
Typical Duration
3-6 months

Detailed Protocol

Administered via subcutaneous injection. CJC-1295 with DAC is typically injected once or twice weekly. Without DAC, it should be injected more frequently. Often stacked with Ipamorelin for optimal results.

About CJC-1295

CJC-1295 is a synthetic analogue of growth hormone releasing hormone (GHRH). It has been modified to increase its half-life and stability. CJC-1295 works by increasing the amount of growth hormone (GH) produced and secreted by the pituitary gland. With DAC (Drug Affinity Complex), it has an extended half-life of about one week.

Research Notes

Studies have shown CJC-1295 significantly increases plasma GH and IGF-1 levels with minimal effect on prolactin and cortisol. The addition of DAC extends the half-life from approximately 30 minutes to one week.

Get Peptide Research Updates

Newsletter signup

Please wait...

Thanks for signing up! You will receive an email to confirm your subscription.

Potential Side Effects

  • •Injection site reaction
  • •Flu-like symptoms (rare)
  • •Water retention
  • •Numbness or tingling in hands/feet

Always consult with a healthcare professional before starting any peptide therapy.